Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis patent CN118255679A offers high yield and safety. Reduces toxic reagents for reliable pharmaceutical intermediate supply chain stability.
Patent CN119264121A reveals Ru-catalyzed C-H activation for high-purity benzopyrone derivatives. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110105362B details a safe, high-yield folic acid synthesis using heteropoly acid catalysts, eliminating hazardous chlorination for reliable API intermediate supply.
Patent CN101891647A details a novel Ubenimex preparation using L-lysine resolution and EDCI/HOAt coupling, ensuring >99.5% purity and robust supply chain reliability.
Patent CN115073250A reveals a mild visible-light method for sp3 C-F bond carboxylation. Discover cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN101830961A details novel ursolic acid esters with enhanced antitumor activity via efficient Claisen-Schmidt condensation and esterification routes suitable for scale-up.
Novel synthesis method for azacycle-derived polyarylmethane antitumor compounds offering mild conditions and high cytotoxic activity for pharmaceutical supply chains.
Novel FeCl3 catalyzed decarboxylation offers safer greener route for beta-isobutylcyanostyrene intermediates reducing toxic reagent reliance significantly.
Patent CN102180794B reveals a mild, aqueous copper-catalyzed nitration method. Achieve high-purity nitrobenzene derivatives with significant cost reduction and supply chain reliability.
Patent CN110452150A reveals a novel chiral phosphoric acid catalyzed synthesis. Offers mild conditions and high enantioselectivity for reliable supply chain integration.
Patent CN102766092A reveals a mild, high-enantioselective route to tetrahydroquinoline derivatives using chiral spiro phosphoric acid, offering significant cost reduction in API manufacturing.
Patent CN111217847B reveals novel thiosilane ligands enabling high-yield aryl boronation with superior purification and industrial scalability for pharma intermediates.
Novel chiral phosphoric acid catalysis enables high-yield indolocyclopentanes production with enhanced supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthesis method for N-N axis chiral compounds offers high enantioselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN117820316B reveals efficient chiral phosphoric acid catalysis. Enables cost reduction and supply chain reliability for anticancer intermediates.
Patent CN115925722B details a scalable copper halide method for tazobactam intermediates. This process offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114524701B reveals a novel organocatalytic route for N-N axis chiral pyrroles with high enantioselectivity and potent anticancer activity.
Patent CN114276244B reveals mild synthesis for carboxylic acids. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN116082217B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high cytotoxic activity, offering cost-effective routes for API manufacturing.
Patent CN113620795B details a novel Rh-catalyzed route to benzocycloheptenones. Discover cost-effective manufacturing and scalable API intermediate production strategies.